Day-case Local Anaesthetic Radiofrequency Thermal Ablation of Benign Prostatic Hyperplasia: A Four-year Follow-up

REFERENCES

• Neal DE, Ramsden PD, Sharpies L, et al. Outcome of elective prostatectomy. Br Med J 1989; 229: 762–7.
   Google Scholar
• Dahlstrand C, Giersson G, Walden M, Pederson S. Transurethral microwave thermotherapy versus transur-ethral resection for symptomatic benign prostatic obstruction: a prospective randomised study with a 2-year follow-up. Br J Urol 1995; 76: 614–8.
   PubMedGoogle Scholar
• Ahmed M, Bell T, Lawrence WT, et al. Transurethral microwave thermotherapy (Prostatron v2.5) compared with transurethral resection of prostate for treatment of benign prostatic hyperplasia: a randomised, controlled, parallel study. Br J Urol 1997; 79: 181–5.
   Google Scholar
• D'Ancona FCH, Francisca EAE, Witjes WPJ, et al. Transurethral resection of prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998; 81: 259–64.
   PubMedGoogle Scholar
• Yerulshalmi A, Fishelovitz Y, Singer D, et al. Localised deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985; 133: 873–6.
   PubMed Web of Science ®Google Scholar
• Carter S St C, Ogden CW. Intraprostatic temperature versus clinical outcome in TUMT: is the response heat dose dependent? J Urol 1994; 151: 416A, 756.
   Google Scholar
• Larson TR, Bostwick DG, Corica A. Temperature correlated histopathological changes following micro-wave thermoablation of obstructed tissue in patients with benign prostatic hyperplasia. Urology 1996; 47: 463–9.
   Google Scholar
• Perrin P. Devonec M, Houdelete P. et al. Transurethral microwave thermotherapy: higher energy protocol improves clinical results. J Urol 1995; 153 (Suppl): 434A.
   Google Scholar
• Brehmer M, Kinn A-C. Transurethral microwave thermotherapy for benign prostatic hyperplasia: sub-jective response and urodynamic changes. Scand J Urol Nephrol 1996; 30: 307–11.
   Google Scholar
• Eliason T, Damber J-E, Terio H. Pressure-flow studies before and after transurethral microwave thermotherapy of benign prostatic hyperplasia using low- and high-energy protocols. Br J Urol 1998; 82: 513–9.
   Google Scholar
• de Wildt MJAM, Debruyne FMJ, de la Rosette JJMCH. High-energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruc-tion. Urology 1996; 48: 416–23.
   Google Scholar
• Bhanot SM, Grigor KM, Hargreave TB, Chisholm GD. A radiofrequency method of thermal tissue ablation for benign prostatic hyperplasia. Urology 1995; 45: 427–34.
   PubMed Web of Science ®Google Scholar
• Dawkins GPC, Harrison NW, Ansell W. Radiofre-quency heat-treatment to the prostate for bladder outlet obstruction associated with benign prostatic hyperplasia: a 4-year outcome study. Br J Urol 1997; 79: 910–4.
   Google Scholar
• Schulman CC, Vanden Bossche M. Hyperthermia and thermotherapy of benign prostatic hyperplasia: a critical review. Eur Urol 1993; 23 (Suppl): 53–9.
   Google Scholar
• Devonec M, Berger N, Fendler JP, et al. Thermoregula-tion during transurethral microwave thermotherapy: experimental and clinical fundamentals. Eur Urol 1993; 23 (Suppl): 63–7.
   Google Scholar
• Tubaro A, St Clair Carter S, de la Rosette J, et al. The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicentre study. J Urol 1995; 153: 1526–30.
   PubMed Web of Science ®Google Scholar
• Petas A, Talija M, Tammela TLJ, et al. The biodegrad-able self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate. Br J Urol 1997; 80: 439–43.
   PubMedGoogle Scholar
• Dahlstrand C, Grundtman S, Pettersson S. High-energy transurethral microwave thermotherapy for large se-verely obstructing prostates and the use of biodegrad-able stents to avoid catheterisation. Br J Urol 1997; 79: 907–9.
   Google Scholar
• Tormala P. Biodegradable self-reinforced composite materials: manufacturing structure and mechanical properties. Clin Mater 1992; 10: 29–34.
   PubMedGoogle Scholar
• Matzkin H. Hyperthermia as a treatment modality in benign prostatic hyperplasia. Urology 1994; 43 (Suppl): 17–20.
   Google Scholar
• Mebust WK, Holtgrewe HL, Cocked AT, Peters PC. Transurethral prostatectomy: immediate and late post-operative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243–7.
   Google Scholar
• Roos NP, Wennberg JE, Mallenka DJ, et al. Mortality and re-operation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320: 1120–4.
   PubMed Web of Science ®Google Scholar
• Hargreave TB, Heynes CF, Kendrick SW, et al. Mortality after transurethral resection and open prosta-tectomy in Scotland. Br J Urol 1996; 77: 547–53.
   PubMedGoogle Scholar
• Nitti VW, Kim Y, Combs AJ. Voiding dysfunction following transurethral resection of the prostate: symp-toms and urodynamic findings. J Urol 1997; 157: 600–3.
   Google Scholar
• Barry MJ, Abrahams TK, Cocked H, et al. Relationship of symptoms of prostatism to commonly used physio-logical and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993; 150: 351–8.
   PubMed Web of Science ®Google Scholar
• de la Rosette BMCH, D'Ancona FCH, Debruyne FMJ. Current status of thermotherapy of the prostate gland. J Urol 1997; 157: 430–6.
   PubMed Web of Science ®Google Scholar
• Larson TR, Collins JM. An accurate technique for detailed prostatic interstitial temperature-mapping in patients receiving microwave thermal treatment. J Endourol 1995; 9: 339–47.
   PubMed Web of Science ®Google Scholar